Propafenone is very effective in the control of paroxysmal supraventricular tachycardia in patients with Wolff-Parkinson-White syndrome; intravenous Propafenone can predict the efficacy of oral therapy. Propafenone administration is not associated with major side effects.
|Translated title of the contribution||Propafenone in the acute treatment and prevention of paroxysmal supraventricular tachycardia in patients with Wolff-Parkinson-White syndrome|
|Number of pages||4|
|Publication status||Published - 1995|
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine